Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Tehostettu sädehoito kemoterapialla (sisplatiini) tai immunoterapialla (nivolumabi) hoidettaessa potilaita, joilla on varhaisen vaiheen, HPV-positiivinen, tupakoimattomaan liittyvä suunnielun syöpä

keskiviikko 11. marraskuuta 2026 päivittänyt: National Cancer Institute (NCI)

Satunnaistettu vaiheen II/III koe tehostetusta sädehoidosta potilaille, joilla on alkuvaiheen, P16-positiivinen, tupakoimattomaan liittyvä suunnielun syöpä

This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillomavirus (HPV)-positive oropharyngeal cancer that is early in its growth and may not have spread to other parts of the body (early-stage), and is not associated with smoking. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial is being done to see if a reduced dose of radiation therapy and nivolumab works as well as standard dose radiation therapy and cisplatin in treating patients with oropharyngeal cancer.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

PRIMARY OBJECTIVES:

I. To demonstrate non-inferiority in terms of progression-free survival (PFS) of concurrent reduced-dose radiation therapy (RT) with cisplatin or concurrent reduced-dose radiation therapy with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase II) (Arm 2 [concurrent reduced-dose RT with cisplatin] was dropped after interim futility analysis in phase II.) II. To demonstrate non-inferiority in terms of progression-free survival (PFS) of concurrent reduced-dose radiation therapy (RT) with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase II) III. To demonstrate co-primary endpoints of non-inferiority of PFS and superiority of quality of life (QOL) as measured by the MD Anderson Dysphagia Inventory (MDADI) of concurrent reduced-dose radiation with cisplatin or concurrent reduced-dose radiation with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase III) (Arm 2 [concurrent reduced-dose RT with cisplatin] was dropped after interim futility analysis in phase II.) IV. To demonstrate co-primary endpoints of non-inferiority of PFS and superiority of quality of life (QOL) as measured by the MD Anderson Dysphagia Inventory [MDADI] of concurrent reduced-dose radiation with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase III)

SECONDARY OBJECTIVES:

I. To compare patterns of failure (local and regional relapse versus distant) and overall survival between the experimental arm and the control arm.

II. To assess long term PFS, overall survival, and toxicity between the experimental arm and the control arm.

III. To determine acute and late toxicity profiles as measured by the Common Terminology Criteria for Adverse Events (CTCAE).

IV. To explore the symptomatic adverse events (AEs) for tolerability of each treatment arm as measured by the Patient-Reported Outcomes (PRO)-CTCAE.

V. To compare changes in patient-reported outcomes (Hearing Handicap Inventory for Adults-Screening [HHIA-S], European Organization for Research and Treatment of Cancer [EORTC]-Quality of Life Questionnaire [QLQ]30) between the experimental arm and the control arm.

VI. To assess the association of fludeoxyglucose F-18 (FDG)-positron emission tomography (PET)/computed tomography (CT) at baseline with locoregional control and PFS.

VII. To estimate the negative predictive value of the 12-14 weeks post-radiation therapy (RT) FDG-PET/CT in terms of locoregional control rates and PFS rates at 1 and 2 years.

EXPLORATORY OBJECTIVES:

I. To collect blood and tissue specimens for future translation research. II. To optimize radiotherapy treatment plan quality assurance methodology for radiotherapy planning and imaging.

III. To compare changes in patient-reported outcomes (European Quality of Life Five Dimension Five Level Scale [EQ-5D-5L]) between the experimental arm and the control arm.

IV. To collect Modified Barium Swallow (MBS) data for future review and analysis.

OUTLINE:

PHASE II: Patients are randomized to 1 of 3 arms.

ARM I: Patients undergo standard dose RT as 70 Gy intensity modulated radiation therapy (IMRT) or image-guided radiation therapy (IGRT) over 6 fractions per week and receive 100 mg/m^2/day cisplatin intravenously (IV) over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive fludeoxyglucose F-18 (FDG) and undergo positron emission tomography (PET)/computed tomography (CT) or CT during screening and during follow up, and undergo magnetic resonance imaging (MRI) during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

ARM II (CLOSED TO ACCRUAL 03-FEB-2023): Patients undergo reduced dose RT as 60 Gy IMRT or IGRT once daily (QD) over 5 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

ARM III: Beginning 1 week prior to radiation, patients receive 240 mg fixed dose nivolumab IV over 30 minutes on day 1. Treatment repeats every 2 weeks (14 days) for up to 6 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo reduced dose RT as 60 Gy IMRT or IGRT over 6 fractions per week for 5 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

PHASE III: Patients are randomized to Arm I and/or Arm III.

After completion of study treatment, patients are followed up at 12-14 weeks, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

384

Vaihe

  • Vaihe 2
  • Vaihe 3

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Ontario
      • Toronto, Ontario, Kanada, M5G 2M9
        • University Health Network-Princess Margaret Hospital
    • Alabama
      • Birmingham, Alabama, Yhdysvallat, 35233
        • University of Alabama at Birmingham Cancer Center
    • Arizona
      • Gilbert, Arizona, Yhdysvallat, 85234
        • Banner MD Anderson Cancer Center
      • Tucson, Arizona, Yhdysvallat, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, Yhdysvallat, 85719
        • University of Arizona Cancer Center-North Campus
    • California
      • Antioch, California, Yhdysvallat, 94531
        • Kaiser Permanente-Deer Valley Medical Center
      • Arroyo Grande, California, Yhdysvallat, 93420
        • PCR Oncology
      • Auburn, California, Yhdysvallat, 95602
        • Sutter Auburn Faith Hospital
      • Auburn, California, Yhdysvallat, 95603
        • Sutter Cancer Centers Radiation Oncology Services-Auburn
      • Bakersfield, California, Yhdysvallat, 93301
        • AIS Cancer Center at San Joaquin Community Hospital
      • Beverly Hills, California, Yhdysvallat, 90211
        • Tower Cancer Research Foundation
      • Cameron Park, California, Yhdysvallat, 95682
        • Sutter Cancer Centers Radiation Oncology Services-Cameron Park
      • Duarte, California, Yhdysvallat, 91010
        • City of Hope Comprehensive Cancer Center
      • Dublin, California, Yhdysvallat, 94568
        • Kaiser Permanente Dublin
      • Encinitas, California, Yhdysvallat, 92024
        • UC San Diego Health System - Encinitas
      • Fremont, California, Yhdysvallat, 94538
        • Kaiser Permanente-Fremont
      • Fresno, California, Yhdysvallat, 93720
        • Kaiser Permanente-Fresno
      • Fresno, California, Yhdysvallat, 93720
        • Fresno Cancer Center
      • Irvine, California, Yhdysvallat, 92618
        • City of Hope at Irvine Lennar
      • La Jolla, California, Yhdysvallat, 92093
        • UC San Diego Moores Cancer Center
      • Lancaster, California, Yhdysvallat, 93534
        • City of Hope Antelope Valley
      • Los Angeles, California, Yhdysvallat, 90033
        • USC / Norris Comprehensive Cancer Center
      • Los Angeles, California, Yhdysvallat, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Yhdysvallat, 90033
        • Los Angeles General Medical Center
      • Marysville, California, Yhdysvallat, 95901
        • Fremont - Rideout Cancer Center
      • Modesto, California, Yhdysvallat, 95356
        • Kaiser Permanente-Modesto
      • Mountain View, California, Yhdysvallat, 94040
        • Palo Alto Medical Foundation-Camino Division
      • Oakland, California, Yhdysvallat, 94611
        • Kaiser Permanente-Oakland
      • Oakland, California, Yhdysvallat, 94611
        • Kaiser Permanente Oakland-Broadway
      • Palo Alto, California, Yhdysvallat, 94304
        • Stanford Cancer Institute Palo Alto
      • Palo Alto, California, Yhdysvallat, 94301
        • Palo Alto Medical Foundation Health Care
      • Rancho Cordova, California, Yhdysvallat, 95670
        • Kaiser Permanente-Rancho Cordova Cancer Center
      • Redwood City, California, Yhdysvallat, 94063
        • Kaiser Permanente- Marshall Medical Offices
      • Richmond, California, Yhdysvallat, 94801
        • Kaiser Permanente-Richmond
      • Rohnert Park, California, Yhdysvallat, 94928
        • Rohnert Park Cancer Center
      • Roseville, California, Yhdysvallat, 95678
        • The Permanente Medical Group-Roseville Radiation Oncology
      • Roseville, California, Yhdysvallat, 95661
        • Kaiser Permanente-Roseville
      • Roseville, California, Yhdysvallat, 95661
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
      • Roseville, California, Yhdysvallat, 95661
        • Sutter Roseville Medical Center
      • Sacramento, California, Yhdysvallat, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Yhdysvallat, 95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento, California, Yhdysvallat, 95814
        • Kaiser Permanente Downtown Commons
      • Sacramento, California, Yhdysvallat, 95823
        • Kaiser Permanente-South Sacramento
      • Sacramento, California, Yhdysvallat, 95823
        • South Sacramento Cancer Center
      • San Diego, California, Yhdysvallat, 92134
        • Naval Medical Center -San Diego
      • San Diego, California, Yhdysvallat, 92103
        • UC San Diego Medical Center - Hillcrest
      • San Francisco, California, Yhdysvallat, 94115
        • Kaiser Permanente-San Francisco
      • San Francisco, California, Yhdysvallat, 94158
        • UCSF Medical Center-Mission Bay
      • San Jose, California, Yhdysvallat, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Jose, California, Yhdysvallat, 95124
        • Stanford Cancer Center South Bay
      • San Leandro, California, Yhdysvallat, 94577
        • Kaiser Permanente San Leandro
      • San Luis Obispo, California, Yhdysvallat, 93401
        • Pacific Central Coast Health Center-San Luis Obispo
      • San Rafael, California, Yhdysvallat, 94903
        • Kaiser San Rafael-Gallinas
      • Santa Clara, California, Yhdysvallat, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • Santa Rosa, California, Yhdysvallat, 95403
        • Kaiser Permanente-Santa Rosa
      • South Pasadena, California, Yhdysvallat, 91030
        • City of Hope South Pasadena
      • South San Francisco, California, Yhdysvallat, 94080
        • Kaiser Permanente Cancer Treatment Center
      • South San Francisco, California, Yhdysvallat, 94080
        • Kaiser Permanente-South San Francisco
      • Stockton, California, Yhdysvallat, 95210
        • Kaiser Permanente-Stockton
      • Sunnyvale, California, Yhdysvallat, 94086
        • Palo Alto Medical Foundation-Sunnyvale
      • Torrance, California, Yhdysvallat, 90509
        • Torrance Memorial Medical Center
      • Torrance, California, Yhdysvallat, 90505
        • Torrance Memorial Physician Network - Cancer Care
      • Torrance, California, Yhdysvallat, 90503
        • City of Hope South Bay
      • Upland, California, Yhdysvallat, 91786
        • City of Hope Upland
      • Vacaville, California, Yhdysvallat, 95688
        • Kaiser Permanente Medical Center-Vacaville
      • Vallejo, California, Yhdysvallat, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Yhdysvallat, 94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora, Colorado, Yhdysvallat, 80045
        • Rocky Mountain Regional VA Medical Center
      • Aurora, Colorado, Yhdysvallat, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, Yhdysvallat, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Colorado Springs, Colorado, Yhdysvallat, 80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs, Colorado, Yhdysvallat, 80907
        • Rocky Mountain Cancer Centers-Penrose
      • Colorado Springs, Colorado, Yhdysvallat, 80920
        • Memorial Hospital North
      • Denver, Colorado, Yhdysvallat, 80210
        • AdventHealth Porter
      • Fort Collins, Colorado, Yhdysvallat, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Yhdysvallat, 80528
        • Cancer Care and Hematology-Fort Collins
      • Greeley, Colorado, Yhdysvallat, 80631
        • UCHealth Greeley Hospital
      • Littleton, Colorado, Yhdysvallat, 80122
        • AdventHealth Littleton
      • Loveland, Colorado, Yhdysvallat, 80538
        • Medical Center of the Rockies
      • Parker, Colorado, Yhdysvallat, 80138
        • AdventHealth Parker
    • Connecticut
      • Hartford, Connecticut, Yhdysvallat, 06102
        • Hartford Hospital
    • Delaware
      • Newark, Delaware, Yhdysvallat, 19713
        • Helen F Graham Cancer Center
      • Newark, Delaware, Yhdysvallat, 19713
        • Delaware Clinical and Laboratory Physicians PA
      • Newark, Delaware, Yhdysvallat, 19713
        • Medical Oncology Hematology Consultants PA
      • Newark, Delaware, Yhdysvallat, 19718
        • Christiana Care Health System-Christiana Hospital
    • Florida
      • Coral Gables, Florida, Yhdysvallat, 33146
        • UM Sylvester Comprehensive Cancer Center at Coral Gables
      • Coral Springs, Florida, Yhdysvallat, 33065
        • UM Sylvester Comprehensive Cancer Center at Coral Springs
      • Deerfield Beach, Florida, Yhdysvallat, 33442
        • UM Sylvester Comprehensive Cancer Center at Deerfield Beach
      • Jupiter, Florida, Yhdysvallat, 33458
        • Jupiter Medical Center
      • Miami, Florida, Yhdysvallat, 33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami, Florida, Yhdysvallat, 33176
        • Miami Cancer Institute
      • Miami, Florida, Yhdysvallat, 33176
        • UM Sylvester Comprehensive Cancer Center at Kendall
      • Orlando, Florida, Yhdysvallat, 32806
        • Orlando Health Cancer Institute
      • Tampa, Florida, Yhdysvallat, 33612
        • Moffitt Cancer Center
      • Tampa, Florida, Yhdysvallat, 33607
        • Moffitt Cancer Center-International Plaza
      • Tampa, Florida, Yhdysvallat, 33612
        • Moffitt Cancer Center - McKinley Campus
      • Wesley Chapel, Florida, Yhdysvallat, 33544
        • Moffitt Cancer Center at Wesley Chapel
    • Georgia
      • Atlanta, Georgia, Yhdysvallat, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Yhdysvallat, 30303
        • Grady Health System
    • Hawaii
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Queen's Medical Center
      • Honolulu, Hawaii, Yhdysvallat, 96817
        • The Cancer Center of Hawaii-Liliha
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Queen's Cancer Cenrer - POB I
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, Yhdysvallat, 96817
        • Hawaii Cancer Care Inc-Liliha
      • Honolulu, Hawaii, Yhdysvallat, 96817
        • Kuakini Medical Center
      • Honolulu, Hawaii, Yhdysvallat, 96817
        • Queen's Cancer Center - Kuakini
      • Honolulu, Hawaii, Yhdysvallat, 96826
        • Kapiolani Medical Center for Women and Children
      • Honolulu, Hawaii, Yhdysvallat, 96819
        • Kaiser Permanente Moanalua Medical Center
      • Lihue, Hawaii, Yhdysvallat, 96766
        • Wilcox Memorial Hospital and Kauai Medical Clinic
      • ‘Aiea, Hawaii, Yhdysvallat, 96701
        • Hawaii Cancer Care - Westridge
      • ‘Aiea, Hawaii, Yhdysvallat, 96701
        • Pali Momi Medical Center
    • Idaho
      • Boise, Idaho, Yhdysvallat, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Yhdysvallat, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Yhdysvallat, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Fruitland, Idaho, Yhdysvallat, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Yhdysvallat, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Yhdysvallat, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Yhdysvallat, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Twin Falls, Idaho, Yhdysvallat, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Aurora, Illinois, Yhdysvallat, 60504
        • Rush-Copley Medical Center
      • Barrington, Illinois, Yhdysvallat, 60010
        • Advocate Good Shepherd Hospital
      • Bloomington, Illinois, Yhdysvallat, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Yhdysvallat, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Yhdysvallat, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, Yhdysvallat, 62801
        • Centralia Oncology Clinic
      • Chicago, Illinois, Yhdysvallat, 60611
        • Northwestern University
      • Chicago, Illinois, Yhdysvallat, 60657
        • Advocate Illinois Masonic Medical Center
      • Chicago, Illinois, Yhdysvallat, 60612
        • Rush MD Anderson Cancer Center
      • Crystal Lake, Illinois, Yhdysvallat, 60014
        • AMG Crystal Lake - Oncology
      • DeKalb, Illinois, Yhdysvallat, 60115
        • Northwestern Medicine Cancer Center Kishwaukee
      • Decatur, Illinois, Yhdysvallat, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Yhdysvallat, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Downers Grove, Illinois, Yhdysvallat, 60515
        • Advocate Good Samaritan Hospital
      • Effingham, Illinois, Yhdysvallat, 62401
        • Crossroads Cancer Center
      • Elgin, Illinois, Yhdysvallat, 60123
        • Advocate Sherman Hospital
      • Eureka, Illinois, Yhdysvallat, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Yhdysvallat, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Yhdysvallat, 61401
        • Western Illinois Cancer Treatment Center
      • Galesburg, Illinois, Yhdysvallat, 61401
        • Illinois CancerCare-Galesburg
      • Geneva, Illinois, Yhdysvallat, 60134
        • Northwestern Medicine Cancer Center Delnor
      • Glenview, Illinois, Yhdysvallat, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Highland Park, Illinois, Yhdysvallat, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Kewanee, Illinois, Yhdysvallat, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Yhdysvallat, 61455
        • Illinois CancerCare-Macomb
      • Maywood, Illinois, Yhdysvallat, 60153
        • Loyola University Medical Center
      • O'Fallon, Illinois, Yhdysvallat, 62269
        • Cancer Care Center of O'Fallon
      • Ottawa, Illinois, Yhdysvallat, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Park Ridge, Illinois, Yhdysvallat, 60068
        • Advocate Lutheran General Hospital
      • Pekin, Illinois, Yhdysvallat, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Yhdysvallat, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, Yhdysvallat, 61637
        • OSF Saint Francis Medical Center
      • Peoria, Illinois, Yhdysvallat, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Yhdysvallat, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Yhdysvallat, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, Yhdysvallat, 61114
        • UW Health Carbone Cancer Center Rockford
      • Shiloh, Illinois, Yhdysvallat, 62269
        • Memorial Hospital East
      • Springfield, Illinois, Yhdysvallat, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, Yhdysvallat, 62702
        • Springfield Clinic
      • Springfield, Illinois, Yhdysvallat, 62781
        • Springfield Memorial Hospital
      • Warrenville, Illinois, Yhdysvallat, 60555
        • Northwestern Medicine Cancer Center Warrenville
      • Washington, Illinois, Yhdysvallat, 61571
        • Illinois CancerCare - Washington
    • Indiana
      • Carmel, Indiana, Yhdysvallat, 46032
        • IU Health North Hospital
      • Indianapolis, Indiana, Yhdysvallat, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Yhdysvallat, 46202
        • Sidney and Lois Eskenazi Hospital
    • Iowa
      • Clive, Iowa, Yhdysvallat, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, Yhdysvallat, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Creston, Iowa, Yhdysvallat, 50801
        • Greater Regional Medical Center
      • Des Moines, Iowa, Yhdysvallat, 50309
        • Iowa Methodist Medical Center
      • Des Moines, Iowa, Yhdysvallat, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Yhdysvallat, 50314
        • Broadlawns Medical Center
      • Des Moines, Iowa, Yhdysvallat, 50316
        • Iowa Lutheran Hospital
      • Des Moines, Iowa, Yhdysvallat, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines, Iowa, Yhdysvallat, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • West Des Moines, Iowa, Yhdysvallat, 50266-7700
        • Methodist West Hospital
      • West Des Moines, Iowa, Yhdysvallat, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Kansas City, Kansas, Yhdysvallat, 66160
        • University of Kansas Cancer Center
      • Lawrence, Kansas, Yhdysvallat, 66044
        • Lawrence Memorial Hospital
      • Olathe, Kansas, Yhdysvallat, 66061
        • The University of Kansas Cancer Center - Olathe
      • Overland Park, Kansas, Yhdysvallat, 66210
        • University of Kansas Cancer Center-Overland Park
      • Salina, Kansas, Yhdysvallat, 67401
        • Salina Regional Health Center
      • Topeka, Kansas, Yhdysvallat, 66606
        • University of Kansas Health System Saint Francis Campus
      • Westwood, Kansas, Yhdysvallat, 66205
        • University of Kansas Hospital-Westwood Cancer Center
    • Kentucky
      • Lexington, Kentucky, Yhdysvallat, 40536
        • University of Kentucky/Markey Cancer Center
      • Louisville, Kentucky, Yhdysvallat, 40202
        • Norton Hospital Pavilion and Medical Campus
      • Louisville, Kentucky, Yhdysvallat, 40202
        • The James Graham Brown Cancer Center at University of Louisville
      • Louisville, Kentucky, Yhdysvallat, 40241
        • Norton Brownsboro Hospital and Medical Campus
      • Louisville, Kentucky, Yhdysvallat, 40202
        • Jewish Hospital
    • Louisiana
      • Baton Rouge, Louisiana, Yhdysvallat, 70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, Yhdysvallat, 70809
        • Louisiana Hematology Oncology Associates LLC
      • Baton Rouge, Louisiana, Yhdysvallat, 70809
        • Mary Bird Perkins Cancer Center
      • Baton Rouge, Louisiana, Yhdysvallat, 70808
        • Our Lady of the Lake Physician Group
      • Metairie, Louisiana, Yhdysvallat, 70006
        • East Jefferson General Hospital
    • Maine
      • Bath, Maine, Yhdysvallat, 04530
        • MaineHealth Coastal Cancer Treatment Center
      • Biddeford, Maine, Yhdysvallat, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Portland, Maine, Yhdysvallat, 04102
        • MaineHealth Maine Medical Center - Portland
      • Rockport, Maine, Yhdysvallat, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Yhdysvallat, 04073
        • MaineHealth Cancer Care Center of York County
      • Sanford, Maine, Yhdysvallat, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, Yhdysvallat, 04074
        • MaineHealth Maine Medical Center- Scarborough
      • South Portland, Maine, Yhdysvallat, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, Yhdysvallat, 21204
        • Greater Baltimore Medical Center
      • Baltimore, Maryland, Yhdysvallat, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Bel Air, Maryland, Yhdysvallat, 21014
        • UM Upper Chesapeake Medical Center
    • Massachusetts
      • Boston, Massachusetts, Yhdysvallat, 02215
        • Dana-Farber Cancer Institute
      • Boston, Massachusetts, Yhdysvallat, 02118
        • Boston Medical Center
    • Michigan
      • Ann Arbor, Michigan, Yhdysvallat, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Bay City, Michigan, Yhdysvallat, 48706
        • McLaren Cancer Institute-Bay City
      • Brighton, Michigan, Yhdysvallat, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, Yhdysvallat, 48114
        • Trinity Health Medical Center - Brighton
      • Brownstown, Michigan, Yhdysvallat, 48183
        • Henry Ford Cancer Institute-Downriver
      • Canton, Michigan, Yhdysvallat, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, Yhdysvallat, 48188
        • Trinity Health Medical Center - Canton
      • Caro, Michigan, Yhdysvallat, 48723
        • Caro Cancer Center
      • Chelsea, Michigan, Yhdysvallat, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, Yhdysvallat, 48118
        • Chelsea Hospital
      • Clarkston, Michigan, Yhdysvallat, 48346
        • McLaren Cancer Institute-Clarkston
      • Clinton Township, Michigan, Yhdysvallat, 48038
        • Henry Ford Macomb Hospital-Clinton Township
      • Dearborn, Michigan, Yhdysvallat, 48126
        • Henry Ford Medical Center-Fairlane
      • Detroit, Michigan, Yhdysvallat, 48202
        • Henry Ford Hospital
      • Detroit, Michigan, Yhdysvallat, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Farmington Hills, Michigan, Yhdysvallat, 48334
        • Weisberg Cancer Treatment Center
      • Flint, Michigan, Yhdysvallat, 48532
        • McLaren Cancer Institute-Flint
      • Flint, Michigan, Yhdysvallat, 48532
        • Singh and Arora Hematology Oncology PC
      • Grand Rapids, Michigan, Yhdysvallat, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, Yhdysvallat, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Grand Rapids, Michigan, Yhdysvallat, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Lansing, Michigan, Yhdysvallat, 48912
        • Mid-Michigan Physicians-Lansing
      • Lansing, Michigan, Yhdysvallat, 48910
        • Karmanos Cancer Institute at McLaren Greater Lansing
      • Lansing, Michigan, Yhdysvallat, 48912
        • University of Michigan Health - Sparrow Lansing
      • Lapeer, Michigan, Yhdysvallat, 48446
        • McLaren Cancer Institute-Lapeer Region
      • Livonia, Michigan, Yhdysvallat, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Marlette, Michigan, Yhdysvallat, 48453
        • Saint Mary's Oncology/Hematology Associates of Marlette
      • Mount Clemens, Michigan, Yhdysvallat, 48043
        • McLaren Cancer Institute-Macomb
      • Niles, Michigan, Yhdysvallat, 49120
        • Corewell Health Lakeland Hospitals - Niles Hospital
      • Novi, Michigan, Yhdysvallat, 48377
        • Henry Ford Medical Center-Columbus
      • Petoskey, Michigan, Yhdysvallat, 49770
        • McLaren Cancer Institute-Northern Michigan
      • Port Huron, Michigan, Yhdysvallat, 48060
        • McLaren-Port Huron
      • Saginaw, Michigan, Yhdysvallat, 48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Yhdysvallat, 48601
        • MyMichigan Medical Center Saginaw
      • Saint Joseph, Michigan, Yhdysvallat, 49085
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
      • Saint Joseph, Michigan, Yhdysvallat, 49085
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
      • Shelby, Michigan, Yhdysvallat, 48315
        • Henry Ford Macomb Health Center - Shelby Township
      • Tawas City, Michigan, Yhdysvallat, 48764
        • MyMichigan Medical Center Tawas
      • West Bloomfield, Michigan, Yhdysvallat, 48322
        • Henry Ford West Bloomfield Hospital
      • West Branch, Michigan, Yhdysvallat, 48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, Yhdysvallat, 49519
        • University of Michigan Health - West
      • Ypsilanti, Michigan, Yhdysvallat, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
    • Minnesota
      • Bemidji, Minnesota, Yhdysvallat, 56601
        • Sanford Joe Lueken Cancer Center
      • Brainerd, Minnesota, Yhdysvallat, 56401
        • Essentia Health Saint Joseph's Medical Center
      • Deer River, Minnesota, Yhdysvallat, 56636
        • Essentia Health - Deer River Clinic
      • Duluth, Minnesota, Yhdysvallat, 55805
        • Essentia Health Cancer Center
      • Duluth, Minnesota, Yhdysvallat, 55805
        • Essentia Health Saint Mary's Medical Center
      • Duluth, Minnesota, Yhdysvallat, 55805
        • Miller-Dwan Hospital
      • Hibbing, Minnesota, Yhdysvallat, 55746
        • Essentia Health Hibbing Clinic
      • Saint Cloud, Minnesota, Yhdysvallat, 56303
        • Coborn Cancer Center at Saint Cloud Hospital
      • Sandstone, Minnesota, Yhdysvallat, 55072
        • Essentia Health Sandstone
      • Virginia, Minnesota, Yhdysvallat, 55792
        • Essentia Health Virginia Clinic
    • Missouri
      • Cape Girardeau, Missouri, Yhdysvallat, 63703
        • Saint Francis Medical Center
      • City of Saint Peters, Missouri, Yhdysvallat, 63376
        • Siteman Cancer Center at Saint Peters Hospital
      • Creve Coeur, Missouri, Yhdysvallat, 63141
        • Siteman Cancer Center at West County Hospital
      • Farmington, Missouri, Yhdysvallat, 63640
        • Parkland Health Center - Farmington
      • Joplin, Missouri, Yhdysvallat, 64804
        • Freeman Health System
      • Kansas City, Missouri, Yhdysvallat, 64154
        • University of Kansas Cancer Center - North
      • Lee's Summit, Missouri, Yhdysvallat, 64064
        • University of Kansas Cancer Center - Lee's Summit
      • North Kansas City, Missouri, Yhdysvallat, 64116
        • University of Kansas Cancer Center at North Kansas City Hospital
      • Rolla, Missouri, Yhdysvallat, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, Yhdysvallat, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Springfield, Missouri, Yhdysvallat, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Yhdysvallat, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Yhdysvallat, 63129
        • Siteman Cancer Center-South County
    • Montana
      • Bozeman, Montana, Yhdysvallat, 59715
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, Yhdysvallat, 59405
        • Benefis Sletten Cancer Institute
    • Nebraska
      • Kearney, Nebraska, Yhdysvallat, 68847
        • CHI Health Good Samaritan
      • Omaha, Nebraska, Yhdysvallat, 68198
        • University of Nebraska Medical Center
    • Nevada
      • Reno, Nevada, Yhdysvallat, 89502
        • Renown Regional Medical Center
    • New Hampshire
      • Lebanon, New Hampshire, Yhdysvallat, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • New Brunswick, New Jersey, Yhdysvallat, 08903
        • Rutgers Cancer Institute of New Jersey
      • Toms River, New Jersey, Yhdysvallat, 08755
        • Community Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Yhdysvallat, 87109
        • New Mexico Oncology Hematology Consultants
      • Albuquerque, New Mexico, Yhdysvallat, 87106
        • University of New Mexico Cancer Center
    • New York
      • Canandaigua, New York, Yhdysvallat, 14424
        • Sands Cancer Center
      • Dansville, New York, Yhdysvallat, 14437
        • Noyes Memorial Hospital/Myers Cancer Center
      • Oswego, New York, Yhdysvallat, 13126
        • Upstate Cancer Center at Oswego
      • Rochester, New York, Yhdysvallat, 14642
        • University of Rochester
      • Rochester, New York, Yhdysvallat, 14620
        • Highland Hospital
      • Stony Brook, New York, Yhdysvallat, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Yhdysvallat, 13210
        • State University of New York Upstate Medical University
      • Syracuse, New York, Yhdysvallat, 13215
        • SUNY Upstate Medical Center-Community Campus
      • Verona, New York, Yhdysvallat, 13478
        • Upstate Cancer Center at Verona
      • Webster, New York, Yhdysvallat, 14580
        • Wilmot Cancer Institute at Webster
    • North Carolina
      • Charlotte, North Carolina, Yhdysvallat, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte, North Carolina, Yhdysvallat, 28204
        • Novant Health Presbyterian Medical Center
      • Charlotte, North Carolina, Yhdysvallat, 28210
        • Atrium Health Pineville/LCI-Pineville
      • Charlotte, North Carolina, Yhdysvallat, 28262
        • Atrium Health University City/LCI-University
      • Charlotte, North Carolina, Yhdysvallat, 28277
        • Levine Cancer Institute-Ballantyne
      • Clemmons, North Carolina, Yhdysvallat, 27012
        • Wake Forest University at Clemmons
      • Concord, North Carolina, Yhdysvallat, 28025
        • Atrium Health Cabarrus/LCI-Concord
      • Gastonia, North Carolina, Yhdysvallat, 28054
        • CaroMont Regional Medical Center
      • Greenville, North Carolina, Yhdysvallat, 27834
        • East Carolina University
      • Huntersville, North Carolina, Yhdysvallat, 28078
        • Novant Health Cancer Institute - Huntersville
      • Huntersville, North Carolina, Yhdysvallat, 28078
        • Novant Health Presbyterian Medical Center Huntersville
      • Kernersville, North Carolina, Yhdysvallat, 27284
        • Novant Health Cancer Institute - Kernersville
      • Matthews, North Carolina, Yhdysvallat, 28105
        • Novant Health Cancer Institute - Matthews
      • Monroe, North Carolina, Yhdysvallat, 28112
        • Atrium Health Union/LCI-Union
      • Mooresville, North Carolina, Yhdysvallat, 28117
        • Novant Health Cancer Institute - Mooresville
      • Mount Airy, North Carolina, Yhdysvallat, 27030
        • Novant Health Cancer Institute - Mount Airy
      • North Wilkesboro, North Carolina, Yhdysvallat, 28659
        • Novant Health Cancer Institute - Wilkesboro
      • Pinehurst, North Carolina, Yhdysvallat, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Salisbury, North Carolina, Yhdysvallat, 28144
        • Novant Health Cancer Institute - Rowan
      • Statesville, North Carolina, Yhdysvallat, 28625
        • Novant Health Cancer Institute - Statesville
      • Statesville, North Carolina, Yhdysvallat, 28677
        • Wake Forest Baptist Health - Hematology Oncology - Statesville
      • Supply, North Carolina, Yhdysvallat, 28462
        • Novant Cancer Institute Radiation Oncology - Supply
      • Thomasville, North Carolina, Yhdysvallat, 27360
        • Novant Health Cancer Institute - Thomasville
      • Wilkesboro, North Carolina, Yhdysvallat, 28659
        • Wake Forest Baptist Health - Wilkes Medical Center
      • Wilmington, North Carolina, Yhdysvallat, 28401
        • Novant Health New Hanover Regional Medical Center
      • Wilmington, North Carolina, Yhdysvallat, 28401
        • Novant Health Cancer Institute Radiation Oncology - Wilmington
      • Winston-Salem, North Carolina, Yhdysvallat, 27157
        • Wake Forest University Health Sciences
      • Winston-Salem, North Carolina, Yhdysvallat, 27103
        • Novant Health Forsyth Medical Center
    • North Dakota
      • Bismarck, North Dakota, Yhdysvallat, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Yhdysvallat, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Yhdysvallat, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Yhdysvallat, 44304
        • Summa Health System - Akron Campus
      • Avon, Ohio, Yhdysvallat, 44011
        • UH Seidman Cancer Center at UH Avon Health Center
      • Barberton, Ohio, Yhdysvallat, 44203
        • Summa Health System - Barberton Campus
      • Chardon, Ohio, Yhdysvallat, 44024
        • Geauga Hospital
      • Cincinnati, Ohio, Yhdysvallat, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Yhdysvallat, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Yhdysvallat, 44109
        • MetroHealth Medical Center
      • Cleveland, Ohio, Yhdysvallat, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Yhdysvallat, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Yhdysvallat, 43210
        • Ohio State University Comprehensive Cancer Center
      • Mansfield, Ohio, Yhdysvallat, 44906
        • Cleveland Clinic Cancer Center Mansfield
      • Mayfield Heights, Ohio, Yhdysvallat, 44124
        • Hillcrest Hospital Cancer Center
      • Medina, Ohio, Yhdysvallat, 44256
        • Summa Health Medina Medical Center
      • Mentor, Ohio, Yhdysvallat, 44060
        • UH Seidman Cancer Center at Lake Health Mentor Campus
      • Middleburg Heights, Ohio, Yhdysvallat, 44130
        • UH Seidman Cancer Center at Southwest General Hospital
      • Parma, Ohio, Yhdysvallat, 44129
        • University Hospitals Parma Medical Center
      • Perrysburg, Ohio, Yhdysvallat, 43551
        • Mercy Health - Perrysburg Hospital
      • Ravenna, Ohio, Yhdysvallat, 44266
        • University Hospitals Portage Medical Center
      • Sandusky, Ohio, Yhdysvallat, 44870
        • North Coast Cancer Care
      • Strongsville, Ohio, Yhdysvallat, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Sylvania, Ohio, Yhdysvallat, 43560
        • ProMedica Flower Hospital
      • Toledo, Ohio, Yhdysvallat, 43623
        • Mercy Health - Saint Anne Hospital
      • Toledo, Ohio, Yhdysvallat, 43608
        • Mercy Health - Saint Vincent Hospital
      • Toledo, Ohio, Yhdysvallat, 43623
        • Mercy Health Sylvania Radiation Oncology Center
      • West Chester, Ohio, Yhdysvallat, 45069
        • University of Cincinnati Cancer Center-West Chester
      • Westlake, Ohio, Yhdysvallat, 44145
        • UH Seidman Cancer Center at Saint John Medical Center
      • Westlake, Ohio, Yhdysvallat, 44145
        • UHHS-Westlake Medical Center
      • Wooster, Ohio, Yhdysvallat, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Yhdysvallat, 73104
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Clackamas, Oregon, Yhdysvallat, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Yhdysvallat, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Newberg, Oregon, Yhdysvallat, 97132
        • Providence Newberg Medical Center
      • Oregon City, Oregon, Yhdysvallat, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Yhdysvallat, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Yhdysvallat, 97225
        • Providence Saint Vincent Medical Center
      • Portland, Oregon, Yhdysvallat, 97227
        • Kaiser Permanente Northwest
    • Pennsylvania
      • Allentown, Pennsylvania, Yhdysvallat, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Altoona, Pennsylvania, Yhdysvallat, 16601
        • UPMC Altoona
      • Beaver, Pennsylvania, Yhdysvallat, 15009
        • UPMC-Heritage Valley Health System Beaver
      • Carlisle, Pennsylvania, Yhdysvallat, 17015
        • Carlisle Regional Cancer Center
      • Chadds Ford, Pennsylvania, Yhdysvallat, 19317
        • Christiana Care Health System-Concord Health Center
      • Chambersburg, Pennsylvania, Yhdysvallat, 17201
        • Chambersburg Hospital
      • Danville, Pennsylvania, Yhdysvallat, 17822
        • Geisinger Medical Center
      • East Norriton, Pennsylvania, Yhdysvallat, 19401
        • Fox Chase Cancer Center - East Norriton Hospital Outpatient Center
      • Ephrata, Pennsylvania, Yhdysvallat, 17522
        • Ephrata Cancer Center
      • Erie, Pennsylvania, Yhdysvallat, 16505
        • UPMC Hillman Cancer Center Erie
      • Farrell, Pennsylvania, Yhdysvallat, 16121
        • UPMC Cancer Center at UPMC Horizon
      • Furlong, Pennsylvania, Yhdysvallat, 18925
        • Fox Chase Cancer Center Buckingham
      • Gettysburg, Pennsylvania, Yhdysvallat, 17325
        • Adams Cancer Center
      • Greensburg, Pennsylvania, Yhdysvallat, 15601
        • UPMC Cancer Centers - Arnold Palmer Pavilion
      • Harrisburg, Pennsylvania, Yhdysvallat, 17109
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
      • Hershey, Pennsylvania, Yhdysvallat, 17033-0850
        • Penn State Milton S Hershey Medical Center
      • Johnstown, Pennsylvania, Yhdysvallat, 15901
        • UPMC-Johnstown/John P. Murtha Regional Cancer Center
      • Lewisburg, Pennsylvania, Yhdysvallat, 17837
        • Geisinger Medical Oncology-Lewisburg
      • Lewistown, Pennsylvania, Yhdysvallat, 17044
        • Lewistown Hospital
      • McKeesport, Pennsylvania, Yhdysvallat, 15132
        • UPMC Cancer Center at UPMC McKeesport
      • Mechanicsburg, Pennsylvania, Yhdysvallat, 17050
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
      • Monroeville, Pennsylvania, Yhdysvallat, 15146
        • Forbes Hospital
      • Monroeville, Pennsylvania, Yhdysvallat, 15146
        • UPMC Cancer Center - Monroeville
      • Moon Township, Pennsylvania, Yhdysvallat, 15108
        • UPMC Hillman Cancer Center in Coraopolis
      • Philadelphia, Pennsylvania, Yhdysvallat, 19111
        • Fox Chase Cancer Center
      • Philadelphia, Pennsylvania, Yhdysvallat, 19107
        • Thomas Jefferson University Hospital
      • Philadelphia, Pennsylvania, Yhdysvallat, 19114
        • Jefferson Torresdale Hospital
      • Philadelphia, Pennsylvania, Yhdysvallat, 19140
        • Temple University Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15213
        • UPMC-Magee Womens Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15232
        • UPMC-Shadyside Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15215
        • UPMC-Saint Margaret
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15237
        • UPMC-Passavant Hospital
      • Pittsburgh, Pennsylvania, Yhdysvallat, 15243
        • UPMC-Saint Clair Hospital Cancer Center
      • Pottsville, Pennsylvania, Yhdysvallat, 17901
        • Geisinger Cancer Services-Pottsville
      • Seneca, Pennsylvania, Yhdysvallat, 16346
        • UPMC Cancer Center at UPMC Northwest
      • Uniontown, Pennsylvania, Yhdysvallat, 15401
        • UPMC Uniontown Hospital Radiation Oncology
      • Washington, Pennsylvania, Yhdysvallat, 15301
        • UPMC Washington Hospital Radiation Oncology
      • West Reading, Pennsylvania, Yhdysvallat, 19611
        • Reading Hospital
      • Wexford, Pennsylvania, Yhdysvallat, 15090
        • Wexford Health and Wellness Pavilion
      • Wilkes-Barre, Pennsylvania, Yhdysvallat, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
      • Williamsport, Pennsylvania, Yhdysvallat, 17754
        • Divine Providence Hospital
      • Willow Grove, Pennsylvania, Yhdysvallat, 19090
        • Asplundh Cancer Pavilion
      • York, Pennsylvania, Yhdysvallat, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, Yhdysvallat, 17403
        • WellSpan Health-York Hospital
      • York, Pennsylvania, Yhdysvallat, 17408
        • UPMC Memorial
    • South Carolina
      • Charleston, South Carolina, Yhdysvallat, 29425
        • Medical University of South Carolina
      • Gaffney, South Carolina, Yhdysvallat, 29341
        • Gibbs Cancer Center-Gaffney
      • Georgetown, South Carolina, Yhdysvallat, 29440
        • Tidelands Georgetown Memorial Hospital
      • Greenville, South Carolina, Yhdysvallat, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Yhdysvallat, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Yhdysvallat, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Yhdysvallat, 29601
        • Saint Francis Hospital
      • Greer, South Carolina, Yhdysvallat, 29650
        • Prisma Health Cancer Institute - Greer
      • Greer, South Carolina, Yhdysvallat, 29651
        • Gibbs Cancer Center-Pelham
      • Rock Hill, South Carolina, Yhdysvallat, 29732
        • Levine Cancer Institute-Rock Hill
      • Rock Hill, South Carolina, Yhdysvallat, 29730
        • Rock Hill Radiation Therapy Center
      • Seneca, South Carolina, Yhdysvallat, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, Yhdysvallat, 29303
        • Spartanburg Medical Center
      • Union, South Carolina, Yhdysvallat, 29379
        • SMC Center for Hematology Oncology Union
    • South Dakota
      • Sioux Falls, South Dakota, Yhdysvallat, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Yhdysvallat, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, Yhdysvallat, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Germantown, Tennessee, Yhdysvallat, 38138
        • The West Clinic - Wolf River
      • Knoxville, Tennessee, Yhdysvallat, 37920
        • University of Tennessee - Knoxville
      • Nashville, Tennessee, Yhdysvallat, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Amarillo, Texas, Yhdysvallat, 79106
        • The Don and Sybil Harrington Cancer Center
    • Utah
      • American Fork, Utah, Yhdysvallat, 84003
        • American Fork Hospital / Huntsman Intermountain Cancer Center
      • Farmington, Utah, Yhdysvallat, 84025
        • Farmington Health Center
      • Logan, Utah, Yhdysvallat, 84321
        • Logan Regional Hospital
      • Murray, Utah, Yhdysvallat, 84107
        • Intermountain Medical Center
      • Ogden, Utah, Yhdysvallat, 84403
        • McKay-Dee Hospital Center
      • Provo, Utah, Yhdysvallat, 84604
        • Utah Valley Regional Medical Center
      • Riverton, Utah, Yhdysvallat, 84065
        • Riverton Hospital
      • Salt Lake City, Utah, Yhdysvallat, 84112
        • Huntsman Cancer Institute/University of Utah
      • Salt Lake City, Utah, Yhdysvallat, 84106
        • Utah Cancer Specialists-Salt Lake City
      • Salt Lake City, Utah, Yhdysvallat, 84143
        • LDS Hospital
      • St. George, Utah, Yhdysvallat, 84770
        • Saint George Regional Medical Center
    • Vermont
      • Saint Johnsbury, Vermont, Yhdysvallat, 05819
        • Dartmouth Cancer Center - North
    • Virginia
      • Fairfax, Virginia, Yhdysvallat, 22031
        • Inova Schar Cancer Institute
      • Fairfax, Virginia, Yhdysvallat, 22033
        • Inova Fair Oaks Hospital
      • Portsmouth, Virginia, Yhdysvallat, 23708-2197
        • Naval Medical Center - Portsmouth
      • Richmond, Virginia, Yhdysvallat, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, Yhdysvallat, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Renton, Washington, Yhdysvallat, 98055
        • Valley Medical Center
      • Seattle, Washington, Yhdysvallat, 98107
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, Yhdysvallat, 98122
        • Swedish Medical Center-First Hill
      • Walla Walla, Washington, Yhdysvallat, 99362
        • Providence Saint Mary Regional Cancer Center
    • Wisconsin
      • Antigo, Wisconsin, Yhdysvallat, 54409
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
      • Appleton, Wisconsin, Yhdysvallat, 54915
        • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
      • Ashland, Wisconsin, Yhdysvallat, 54806
        • Duluth Clinic Ashland
      • Ashland, Wisconsin, Yhdysvallat, 54806
        • Northwest Wisconsin Cancer Center
      • Brookfield, Wisconsin, Yhdysvallat, 53045
        • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
      • Burlington, Wisconsin, Yhdysvallat, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Chilton, Wisconsin, Yhdysvallat, 53014
        • Ascension Calumet Hospital-Chilton
      • Eau Claire, Wisconsin, Yhdysvallat, 54701
        • HSHS Sacred Heart Hospital
      • Franklin, Wisconsin, Yhdysvallat, 53132
        • Ascension Southeast Wisconsin Hospital - Franklin
      • Franklin, Wisconsin, Yhdysvallat, 53132
        • Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
      • Germantown, Wisconsin, Yhdysvallat, 53022
        • Aurora Health Care Germantown Health Center
      • Grafton, Wisconsin, Yhdysvallat, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, Yhdysvallat, 54311
        • Aurora BayCare Medical Center
      • Green Bay, Wisconsin, Yhdysvallat, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Green Bay, Wisconsin, Yhdysvallat, 54303
        • Saint Vincent Hospital Cancer Center at Saint Mary's
      • Hayward, Wisconsin, Yhdysvallat, 54843
        • Essentia Health-Hayward Clinic
      • Johnson Creek, Wisconsin, Yhdysvallat, 53038
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
      • Kenosha, Wisconsin, Yhdysvallat, 53142
        • Aurora Cancer Care-Kenosha South
      • La Crosse, Wisconsin, Yhdysvallat, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Yhdysvallat, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marinette, Wisconsin, Yhdysvallat, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Menomonee Falls, Wisconsin, Yhdysvallat, 53051
        • Froedtert Menomonee Falls Hospital
      • Mequon, Wisconsin, Yhdysvallat, 53097
        • Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon
      • Milwaukee, Wisconsin, Yhdysvallat, 53226
        • Medical College of Wisconsin
      • Milwaukee, Wisconsin, Yhdysvallat, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, Yhdysvallat, 53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee, Wisconsin, Yhdysvallat, 53233
        • Aurora Sinai Medical Center
      • Milwaukee, Wisconsin, Yhdysvallat, 53210
        • Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee
      • Milwaukee, Wisconsin, Yhdysvallat, 53211
        • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus
      • Milwaukee, Wisconsin, Yhdysvallat, 53215
        • Ascension Saint Francis Hospital-Milwaukee
      • Oshkosh, Wisconsin, Yhdysvallat, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Oshkosh, Wisconsin, Yhdysvallat, 54904
        • Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
      • Racine, Wisconsin, Yhdysvallat, 53406
        • Aurora Cancer Care-Racine
      • Racine, Wisconsin, Yhdysvallat, 53405
        • Ascension All Saints Hospital-Spring Street-Racine
      • Rhinelander, Wisconsin, Yhdysvallat, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Sheboygan, Wisconsin, Yhdysvallat, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Spooner, Wisconsin, Yhdysvallat, 54801
        • Essentia Health-Spooner Clinic
      • Stevens Point, Wisconsin, Yhdysvallat, 54481
        • Aspirus Cancer Care - Stevens Point
      • Summit, Wisconsin, Yhdysvallat, 53066
        • Aurora Medical Center in Summit
      • Superior, Wisconsin, Yhdysvallat, 54880
        • Essentia Health Saint Mary's Hospital - Superior
      • Two Rivers, Wisconsin, Yhdysvallat, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Wausau, Wisconsin, Yhdysvallat, 54401
        • Aspirus Cancer Care-Wausau
      • Wauwatosa, Wisconsin, Yhdysvallat, 53226
        • Aurora Cancer Care-Milwaukee West
      • Wauwatosa, Wisconsin, Yhdysvallat, 53226
        • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
      • West Allis, Wisconsin, Yhdysvallat, 53227
        • Aurora West Allis Medical Center
      • West Bend, Wisconsin, Yhdysvallat, 53095
        • Froedtert West Bend Hospital/Kraemer Cancer Center
      • Wisconsin Rapids, Wisconsin, Yhdysvallat, 54494
        • Aspirus Cancer Care - Wisconsin Rapids

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Pathologically (histologically or cytologically) proven diagnosis of squamous cell carcinoma (including the histological variants papillary squamous cell carcinoma and basaloid squamous cell carcinoma but not neuroendocrine phenotype) of the oropharynx (tonsil, base of tongue, soft palate, or oropharyngeal walls); cytologic diagnosis from a cervical lymph node is sufficient in the presence of clinical evidence of a primary tumor in the oropharynx. Clinical evidence should be documented, may consist of palpation, imaging, or endoscopic evaluation, and should be sufficient to estimate the size of the primary (for T stage)

  • Patients must have clinically or radiographically evident measurable disease at the primary site or at nodal stations. Simple tonsillectomy or local excision of the primary without removal of nodal disease is permitted, as is excision removing gross nodal disease but with intact primary site. Limited neck dissections retrieving =< 4 nodes are permitted and considered as non-therapeutic nodal excisions

  • P16-positive based on local site immunohistochemical tissue staining (defined as greater than 70% strong diffuse nuclear or nuclear and cytoplasmic staining of tumor cells). Fine needle aspiration (FNA) biopsy specimens may be used as the sole diagnostic tissue. Centers are encouraged to contact the pathology chair for clarification

    • Note: Institutions must screen patients, whose tumors must be p16-positive by immunohistochemistry (IHC) in order to be eligible for the trial using a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory. A rigorous laboratory accreditation process similar to the United States (U.S.) CLIA certification, such as the provincial accreditation status offered by the Ontario Laboratory Accreditation (OLA) Program in Canada, the College of American Pathologists (CAP), or an equivalent accreditation in other countries, is acceptable. The p16-positive results must be reported on the pathology report being submitted
    • Note: If p16 result is equivocal, positive HPV deoxyribonucleic acid (DNA) test of tumor specimen is acceptable and fulfills the eligibility criteria
  • Clinical stage T1-2, N1, M0 (American Joint Committee on Cancer [AJCC], 8th edition [ed.]) or T3, N0-N1, M0 (AJCC, 8th ed.) including no distant metastases based on the following diagnostic workup:

    • General history and physical examination within 56 days prior to registration;

    • Exam with laryngopharyngoscopy (mirror or in office direct procedure acceptable) within 70 days prior to registration;

    • One of the following imaging studies is required within 56 days prior to registration:

      • FDG-PET/CT of the neck and chest (with or without contrast); FDG-PET/CT scan is strongly preferred and highly recommended to be used for eligibility OR
      • Chest CT (with or without contrast)
    • One of the following imaging studies is required within 28 days prior to registration:

      • A diagnostic CT scan of neck (with contrast and of diagnostic quality) OR
      • An magnetic resonance imaging (MRI) of the neck (with contrast and of diagnostic quality)
      • Note: A diagnostic quality CT or MRI with contrast or FDG-PET/CT scan of neck performed for the purposes of radiation planning may serve as both staging and planning tools
  • Patients must provide their personal smoking history prior to registration. The lifetime cumulative history cannot exceed 10 pack-years. The following formula is used to calculate the pack-years during the periods of smoking in the patient's life; the cumulative total of the number of pack-years during each period of active smoking is the lifetime cumulative history

    • Number of pack-years = [Frequency of smoking (number of cigarettes per day) x duration of cigarette smoking (years)] / 20
    • Note: Twenty cigarettes is considered equivalent to one pack. The effect of non-cigarette tobacco products on the survival of patients with p16-positive oropharyngeal cancers is undefined. While there are reportedly increased risks of head and neck cancer associated with sustained heavy cigar and pipe use (Wyss 2013), such sustained use of non-cigarette products is unusual and does not appear to convey added risk with synchronous cigarette smoking. Cigar and pipe tobacco consumption is therefore not included in calculating the lifetime pack-years. Marijuana consumption is likewise not considered in this calculation. There is no clear scientific evidence regarding the role of chewing tobacco-containing products in this disease, although this is possibly more concerning given the proximity of the oral cavity and oropharynx. In any case, investigators are discouraged from enrolling patients with a history of very sustained use (such as several years or more) of non-cigarette tobacco products alone
  • Zubrod performance status of 0-1 within 14 days prior to registration

  • Age >= 18

  • Absolute neutrophil count >= 1,500/mcL (within 14 days prior to registration)

  • Platelets >= 100,000/mcL (within 14 days prior to registration)

  • Hemoglobin >= 8.0 g/dL (within 14 days prior to registration) (Note: use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)

  • Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (within 14 days prior to registration)

  • Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic transaminase [SGOT]) or alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 3.0 x institutional ULN (within 14 days prior to registration)

  • Serum creatinine =< 1.5 x ULN OR creatinine clearance (CrCl) >= 50 mL/min (if using the Cockcroft-Gault formula) (within 14 days prior to registration)

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial

  • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated

    • Note: Known positive test for hepatitis B virus surface antigen (HBV sAg) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy. Patients who are immune to hepatitis B (anti-hepatitis B surface antibody positive) are eligible (e.g. patients immunized against hepatitis B)
  • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment for the hepatitis, they are eligible if they have an undetectable HCV viral load.

    • Note: Known positive test for hepatitis C virus ribonucleic acid (HCV RNA) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy
  • For women of childbearing potential (WOCBP), negative serum or urine pregnancy test within 24 hours prior to registration

    • Women of childbearing potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal. Menopause is defined clinically as 12 months of amenorrhea in a woman over 45 in the absence of other biological or physiological causes. In addition, women under the age of 55 must have a documented serum follicle stimulating hormone (FSH) level less than 40 mIU/mL
  • Women of childbearing potential (WOCBP) and men who are sexually active with WOCBP must be willing to use an adequate method of contraception during and after treatment

  • The patient or a legally authorized representative must provide study-specific informed consent prior to study entry

  • Only English, Spanish, or French speaking patients are eligible to participate as these are the only languages for which the mandatory dysphagia-related patient reported instrument (MDADI) is available

Exclusion Criteria:

  • Clinical stages T0; T4; T1-2, N0; or any N2 (AJCC, 8th ed)

  • Recurrent disease

  • Definitive clinical or radiologic evidence of metastatic disease or adenopathy below the clavicles

  • Cancers considered to be from an oral cavity site (oral tongue, floor mouth, alveolar ridge, buccal or lip), or the nasopharynx, hypopharynx, or larynx, even if p16-positive, or histologies of adenosquamous, verrucous, or spindle cell carcinomas

  • Carcinoma of the neck of unknown primary site origin (T0 is ineligible, even if p16-positive)

  • Radiographically matted nodes, defined as 3 abutting nodes with loss of the intervening fat plane

  • Supraclavicular nodes, defined as nodes centered below the level of the cricoid cartilage

  • Gross total excision of both primary and nodal disease; this includes tonsillectomy, local excision of primary site, and nodal excision that removes all clinically and radiographically evident disease. In other words, to participate in this protocol, the patient must have clinically or radiographically evident gross disease for which disease response can be assessed

  • Patients with simultaneous primary cancers or separate bilateral primary tumor sites are excluded with the exception of patients with bilateral tonsil cancers

  • Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 1095 days (3 years) (of note, the exclusion applies only for invasive cancers such that carcinoma in situ of the breast, oral cavity, or cervix are all permissible)

  • Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable

  • Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields

  • Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways

  • History of severe hypersensitivity reaction to any monoclonal antibody.

  • Severe, active co-morbidity defined as follows:

    • Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months
    • Transmural myocardial infarction within the last 6 months
    • Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
    • Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days of registration
    • Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
    • Acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease Control and Prevention (CDC) definition with immune compromise greater than that noted; note, however, that HIV testing is not required for entry into this protocol. The need to exclude patients with AIDS from this protocol is necessary because the treatments involved in this protocol may be significantly immunosuppressive. Protocol-specific requirements may also exclude immuno-compromised patients
    • Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of registration. Inhaled or topical steroids and adrenal replacement doses < 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease
    • Patients with active autoimmune disease requiring systemic treatment (i.e. disease modifying agents, corticosteroids, or immunosuppressive drugs) should be excluded. These include but are not limited to patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), rheumatoid arthritis, connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome should be excluded because of the risk of recurrence or exacerbation of disease
    • Note: Patients are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger (precipitating event)
  • Patients who are pregnant, nursing, or expecting to conceive or father children

  • Prior allergic reaction to cisplatin

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Arm I (Standard RT + cisplatin)

Patients undergo standard dose RT as 70 Gy IMRT or IGRT over 6 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

Ancillary studies

Muut nimet:
  • Elämänlaadun arviointi

Given IV

Muut nimet:
  • CDDP
  • Cis-diamiinidikloridiplatina
  • Cismaplat
  • Sisplatina
  • Neoplatiini
  • Platinol
  • Abiplatiini
  • Blastolem
  • Briplatiini
  • Cis-diamiini-diklooriplatina
  • Cis-diamiinidikloori platina (II)
  • Cis-diamiinidiklooriplatina
  • Cis-diklooriamiini platina (II)
  • Cis-platina diamiinidikloridi
  • Cis-platina
  • Cis-platina II
  • Cis-platina II -diamiinidikloridi
  • Sisplatyyli
  • Citoplatino
  • Citosiini
  • Cysplatyna
  • DDP
  • Lederplatiini
  • Metaplatiini
  • Peyronen kloridi
  • Peyronen suola
  • Placis
  • Plastistil
  • Platamiini
  • Platiblastiini
  • Platiblastin-S
  • Platinex
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoksaani
  • Platina
  • Platina Diamminodikloridi
  • Platiran
  • Platistin
  • Platosiini

Undergo blood sample collection

Muut nimet:
  • Biologinen näytekokoelma
  • Bionäyte kerätty
  • Näytteiden kokoelma
  • Näytteenotto

Undergo CT

Muut nimet:
  • CT
  • KISSA
  • Kerroskuvaus
  • Aksiaalinen tietokonetomografia
  • Tietokoneistettu aksiaalinen tomografia
  • Tietokonetomografia
  • tomografia
  • Tietokoneistettu aksiaalinen tomografia (menettely)
  • Tietokonetomografia (CT).
  • Diagnostinen CAT -skannaus
  • Diagnostinen kissan skannauspalvelutyyppi

Undergo MRI

Muut nimet:
  • MRI
  • Magneettinen resonanssi
  • Magneettiresonanssikuvausskannaus
  • Lääketieteellinen kuvantaminen, magneettiresonanssi / ydinmagneettinen resonanssi
  • HERRA
  • MR-kuvaus
  • MRI-skannaus
  • NMR-kuvaus
  • NMRI
  • Ydinmagneettinen resonanssikuvaus
  • Magneettiresonanssikuvaus (MRI)
  • sMRI
  • Magneettiresonanssikuvaus (menettely)
  • MRI:t
  • Rakenne MRI

Ancillary studies

Undergo PET

Muut nimet:
  • Lääketieteellinen kuvantaminen, positroniemissiotomografia
  • LEMMIKKI
  • PET-skannaus
  • Positroniemissiotomografiaskannaus
  • Positroniemissiotomografia
  • PT
  • Positroniemissiotomografia (menettely)

Undergo IMRT

Muut nimet:
  • IMRT
  • Intensity Modulated RT
  • Intensiteettimoduloitu sädehoito
  • Sädehoito, intensiteettimoduloitu sädehoito
  • Intensiteettimoduloitu sädehoito (menettely)

Receive FDG

Muut nimet:
  • 18FDG
  • FDG
  • Fludeoksiglukoosi F18
  • Fludeoksiglukoosi (18F)
  • Fluori-18 2-fluori-2-deoksi-D-glukoosi
  • Fluorodeoksiglukoosi F18

Undergo tissue biopsy

Muut nimet:
  • Bx
  • BIOPSY_TYPE
  • Biopsia

Undergo IGRT

Muut nimet:
  • IGRT
  • kuvaohjattu sädehoito
  • Kuvaohjattu sädehoito
Kokeellinen: Arm II (Reduced RT + cisplatin)

Patients undergo reduced dose RT as 60 Gy IMRT or IGRT QD over 5 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

Ancillary studies

Muut nimet:
  • Elämänlaadun arviointi

Given IV

Muut nimet:
  • CDDP
  • Cis-diamiinidikloridiplatina
  • Cismaplat
  • Sisplatina
  • Neoplatiini
  • Platinol
  • Abiplatiini
  • Blastolem
  • Briplatiini
  • Cis-diamiini-diklooriplatina
  • Cis-diamiinidikloori platina (II)
  • Cis-diamiinidiklooriplatina
  • Cis-diklooriamiini platina (II)
  • Cis-platina diamiinidikloridi
  • Cis-platina
  • Cis-platina II
  • Cis-platina II -diamiinidikloridi
  • Sisplatyyli
  • Citoplatino
  • Citosiini
  • Cysplatyna
  • DDP
  • Lederplatiini
  • Metaplatiini
  • Peyronen kloridi
  • Peyronen suola
  • Placis
  • Plastistil
  • Platamiini
  • Platiblastiini
  • Platiblastin-S
  • Platinex
  • Platinol-AQ
  • Platinol-AQ VHA Plus
  • Platinoksaani
  • Platina
  • Platina Diamminodikloridi
  • Platiran
  • Platistin
  • Platosiini

Undergo blood sample collection

Muut nimet:
  • Biologinen näytekokoelma
  • Bionäyte kerätty
  • Näytteiden kokoelma
  • Näytteenotto

Undergo CT

Muut nimet:
  • CT
  • KISSA
  • Kerroskuvaus
  • Aksiaalinen tietokonetomografia
  • Tietokoneistettu aksiaalinen tomografia
  • Tietokonetomografia
  • tomografia
  • Tietokoneistettu aksiaalinen tomografia (menettely)
  • Tietokonetomografia (CT).
  • Diagnostinen CAT -skannaus
  • Diagnostinen kissan skannauspalvelutyyppi

Undergo MRI

Muut nimet:
  • MRI
  • Magneettinen resonanssi
  • Magneettiresonanssikuvausskannaus
  • Lääketieteellinen kuvantaminen, magneettiresonanssi / ydinmagneettinen resonanssi
  • HERRA
  • MR-kuvaus
  • MRI-skannaus
  • NMR-kuvaus
  • NMRI
  • Ydinmagneettinen resonanssikuvaus
  • Magneettiresonanssikuvaus (MRI)
  • sMRI
  • Magneettiresonanssikuvaus (menettely)
  • MRI:t
  • Rakenne MRI

Ancillary studies

Undergo PET

Muut nimet:
  • Lääketieteellinen kuvantaminen, positroniemissiotomografia
  • LEMMIKKI
  • PET-skannaus
  • Positroniemissiotomografiaskannaus
  • Positroniemissiotomografia
  • PT
  • Positroniemissiotomografia (menettely)

Undergo IMRT

Muut nimet:
  • IMRT
  • Intensity Modulated RT
  • Intensiteettimoduloitu sädehoito
  • Sädehoito, intensiteettimoduloitu sädehoito
  • Intensiteettimoduloitu sädehoito (menettely)

Receive FDG

Muut nimet:
  • 18FDG
  • FDG
  • Fludeoksiglukoosi F18
  • Fludeoksiglukoosi (18F)
  • Fluori-18 2-fluori-2-deoksi-D-glukoosi
  • Fluorodeoksiglukoosi F18

Undergo tissue biopsy

Muut nimet:
  • Bx
  • BIOPSY_TYPE
  • Biopsia

Undergo IGRT

Muut nimet:
  • IGRT
  • kuvaohjattu sädehoito
  • Kuvaohjattu sädehoito
Kokeellinen: Arm III (Reduced RT + nivolumab)

Beginning 1 week prior to radiation, patients receive 240 mg fixed dose nivolumab IV over 30 minutes on day 1. Treatment repeats every 2 weeks (14 days) for up to 6 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo reduced dose RT as 60 Gy IMRT or IGRT over 6 fractions per week for 5 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.

Ancillary studies

Muut nimet:
  • Elämänlaadun arviointi

Undergo blood sample collection

Muut nimet:
  • Biologinen näytekokoelma
  • Bionäyte kerätty
  • Näytteiden kokoelma
  • Näytteenotto

Undergo CT

Muut nimet:
  • CT
  • KISSA
  • Kerroskuvaus
  • Aksiaalinen tietokonetomografia
  • Tietokoneistettu aksiaalinen tomografia
  • Tietokonetomografia
  • tomografia
  • Tietokoneistettu aksiaalinen tomografia (menettely)
  • Tietokonetomografia (CT).
  • Diagnostinen CAT -skannaus
  • Diagnostinen kissan skannauspalvelutyyppi

Ancillary studies

Undergo PET

Muut nimet:
  • Lääketieteellinen kuvantaminen, positroniemissiotomografia
  • LEMMIKKI
  • PET-skannaus
  • Positroniemissiotomografiaskannaus
  • Positroniemissiotomografia
  • PT
  • Positroniemissiotomografia (menettely)

Given IV

Muut nimet:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumab Biosimilar CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumab Biosimilar ABP 206
  • BCD-263
  • Nivolumab Biosimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Undergo IMRT

Muut nimet:
  • IMRT
  • Intensity Modulated RT
  • Intensiteettimoduloitu sädehoito
  • Sädehoito, intensiteettimoduloitu sädehoito
  • Intensiteettimoduloitu sädehoito (menettely)

Receive FDG

Muut nimet:
  • 18FDG
  • FDG
  • Fludeoksiglukoosi F18
  • Fludeoksiglukoosi (18F)
  • Fluori-18 2-fluori-2-deoksi-D-glukoosi
  • Fluorodeoksiglukoosi F18

Undergo tissue biopsy

Muut nimet:
  • Bx
  • BIOPSY_TYPE
  • Biopsia

Undergo IGRT

Muut nimet:
  • IGRT
  • kuvaohjattu sädehoito
  • Kuvaohjattu sädehoito

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Progression-free Survival (PFS) (Phase II) (Percentage of Participants Alive Without Progression)
Aikaikkuna: From randomization to first progression or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.

Progression is defined as local-regional progression or recurrence, distant metastasis, death due to any reason, salvage surgery of primary with tumor present/unknown, salvage neck dissection with tumor present/unknown, > 20 weeks from end of radiation therapy. Progression-free survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis.

The primary phase IIR endpoint is tested using a confidence interval (CI) approach with each experimental arm compared to the standard arm (Arm 1).

From randomization to first progression or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
Progression-free Survival (Phase III) (Percentage of Participants Alive Without Progression)
Aikaikkuna: From randomization to first progression or last follow-up. Maximum follow-up was 4.6 years.

Progression is defined as local-regional progression or recurrence, distant metastasis, death due to any reason, salvage surgery of primary with tumor present/unknown, salvage neck dissection with tumor present/unknown, > 20 weeks from end of radiation therapy. Progression-free survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis.

From randomization to first progression or last follow-up. Maximum follow-up was 4.6 years.
MD Anderson Dysphagia Inventory (MDADI) Global Quality of Life (QOL) Score
Aikaikkuna: Baseline to two years

The M. D. Anderson Dysphagia Inventory (MDADI) assesses how patients view their swallowing ability as a result of treatment and how this affects their QOL. It consists of a global quality of life question and a functional, emotional, and physical subscale. The global QOL question ranges from 1 to 5 and multiplied by 20 to obtain a score with a range of 0 to 100. Higher scores indicate better functioning.

Baseline to two years

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Locoregional Failure (Percentage of Participants With Locoregional Failure)
Aikaikkuna: From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.

Locoregional failure is defined as local-regional progression or recurrence, death due to study cancer or unknown causes, salvage neck dissection with tumor present/unknown. Locoregional failure rates are estimated the cumulative incidence method, treating distant metastasis and death due to any reason other than study cancer or unknown as competing risks, and otherwise censoring participants alive at time of analysis. Each experimental arm is compared to the standard arm (Arm I).

From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
Distant Failure (Percentage of Participants With Distant Failure)
Aikaikkuna: From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.

Distant failure is defined as the occurrence of distant metastasis. Distant failure rates are estimated the cumulative incidence method, treating local-regional progression or recurrence, death due to any reason, salvage neck dissection with tumor present/unknown as competing risks, and otherwise censoring participants alive at time of analysis. Each experimental arm is compared to the standard arm (Arm I).

From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
Overall Survival (Percentage of Participants Alive)
Aikaikkuna: From randomization to death from any cause or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.

Survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis.

From randomization to death from any cause or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
Number of Participants by Highest Grade Adverse Event Reported
Aikaikkuna: From randomization to last known follow-up. Maximum follow-up at the time of analysis was 4.6 years.

Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 grades adverse event severity as follows: 1 = mild, 2 = moderate, 3 = severe, 4 = life-threatening, 5 = death related to adverse event. Summary data is provided in this outcome measure; see Adverse Events Module for specific adverse event data.

From randomization to last known follow-up. Maximum follow-up at the time of analysis was 4.6 years.
Hearing
Aikaikkuna: Baseline up to 24 months from end of radiation therapy (RT)

Measured as Hearing Handicap Inventory for Adults-Screening (HHIA-S).

Baseline up to 24 months from end of radiation therapy (RT)
Quality of Life
Aikaikkuna: Baseline up to 24 months from end of RT

Measured by the European Organization for Research and Treatment of Cancer (EORTC)-Quality of Life Questionnaire (QLQ)30.

Baseline up to 24 months from end of RT
Fludeoxyglucose F-18 (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) Locoregional Control
Aikaikkuna: Up to 6 years

Will be associated with PFS.

Up to 6 years
Negative Predictive Value of Post-RT FDG-PET/CT for Locoregional Control
Aikaikkuna: At 1 and 2 years

The negative predictive value of FDG-PET/CT for locoregional control will be estimated using binomial proportions and confidence intervals based on normal approximation.

At 1 and 2 years
Negative Predictive Value of Post-RT FDG-PET/CT for PFS
Aikaikkuna: At 1 and 2 years

The negative predictive value of FDG-PET/CT PFS will be estimated using binomial proportions and confidence intervals based on normal approximation.

At 1 and 2 years
Incidence of Adverse Events
Aikaikkuna: Up to 6 years

Measured using Patient-Reported Outcomes (PRO)-CTCAE. For each symptom, counts and frequencies will be provided for the worst score experienced by the patient by treatment arm. The proportion of patients with scores >= 1 and >= 3 will be compared between groups using a Chi-square test, or Fisher's exact test if cell frequencies are < 5, using a significance level of 0.05. Analysis of changes in patient reported outcomes over time will analyzed by fitting generalized estimating equations (GEE) models using a logit link (dichotomizing the symptom scores as 0 vs. > 1 and 0-2 vs. 3-4) with time of assessment, treatment arm, and treatment-by-time interaction terms in the model.

Up to 6 years

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Quality of Life
Aikaikkuna: Baseline up to 24 months from end of RT

Measured by EuroQol-5 Dimensional- 5 Level (EQ-5D-5L).

Baseline up to 24 months from end of RT
Swallowing Physiology
Aikaikkuna: Up to 6 years

Measured by a Modified Barium Swallow (MBS) test. The proportion of aspiration for each arm will be estimated assuming a binomial distribution and between arm comparison will be performed using a Fisher's exact test.

Up to 6 years
Locoregional Control for Patients With Post-RT FDG-PET/CT
Aikaikkuna: At 12-14 weeks post-RT

Locoregional control rates will be compared between negative and positive/undetermined patients. Cox proportional hazards models will be used to determine whether there are differences between these two groups, while adjusting for treatment arm and other covariates (cause-specific Cox models for locoregional failure).

At 12-14 weeks post-RT
PFS for Patients With Post-RT FDG-PET/CT
Aikaikkuna: At 12-14 weeks post-RT

PFS rates will be compared between negative and positive/undetermined patients. Cox proportional hazards models will be used to determine whether there are differences between these two groups, while adjusting for treatment arm and other covariates (cause-specific Cox models for locoregional failure).

At 12-14 weeks post-RT

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Sue S Yom, NRG Oncology

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Keskiviikko 9. lokakuuta 2019

Ensisijainen valmistuminen (Todellinen)

Perjantai 1. maaliskuuta 2024

Opintojen valmistuminen (Arvioitu)

Perjantai 11. joulukuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 15. toukokuuta 2019

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 15. toukokuuta 2019

Ensimmäinen Lähetetty (Todellinen)

Torstai 16. toukokuuta 2019

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 13. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 11. marraskuuta 2026

Viimeksi vahvistettu

Maanantai 1. kesäkuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • NCI-2019-03015
  • U10CA180868 (Yhdysvaltain NIH-apuraha/sopimus)
  • NCI-2019-03015 (Rekisterin tunniste: CTRP (Clinical Trial Reporting Program))
  • NRG-HN005 (Muu tunniste: CTEP)
  • NRG-HN005 (Muu tunniste: NRG Oncology)

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

JOO

IPD-suunnitelman kuvaus

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Joo

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa